Metabolic syndrome and breast cancer prognosis

Breast Cancer Research and Treatment

Volumn 147, Issue 1, 2014, Pages 159-165

  Berrino, Franco ^a   Villarini, Anna ^a   Traina, Adele ^b   Bonanni, Bernardo ^c   Panico, Salvatore ^d   Mano, Maria Piera ^e,f   Mercandino, Angelica ^g   Galasso, Rocco ^h   Barbero, Maggiorino ⁱ   Simeoni, Milena ^j   Bassi, Maria Chiara ^k   Consolaro, Elena ^l   Johansson, Harriet ^c   Zarcone, Maurizio ^b   Bruno, Eleonora ^a   Gargano, Giuliana ^a   Venturelli, Elisabetta ^a   Pasanisi, Patrizia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ARNAS Ospedali Civico e Benfratelli G di Cristina e M Ascoli   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Dipartimento Scienze Chirurgiche Study University   (Italy)

^f CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^g Edo Tempia Foundation   (Italy)

^h REFERRAL CANCER CENTER OF BASILICATA   (Italy)

ⁱ CARDINAL MASSAIA HOSPITAL   (Italy)

^j Associazione LUMEN   (Italy)

^k Azienda Sanitaria Locale (ASL) di Mantova   (Italy)

^l Azienda Sanitaria Locale   (Italy)

more..

Author keywords

Breast cancer prognosis; Diet; Metabolic syndrome; Physical activity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVOR; CHRONIC DISEASE; DISTANT METASTASIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROGNOSIS; BODY MASS; BREAST NEOPLASMS; CANCER GRADING; COMPLICATION; MIDDLE AGED; MORTALITY; RISK FACTOR; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 84906054764     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3076-6     Document Type: Article

References (52)

1. De Angelis R, Sant M, Coleman MP et al (2014) Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 15:23-34
2. Edwards BK, Noone AM, Mariotto AB et al. (2013) Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. doi:10.1002/cncr.28509
3. De Angelis R, Tavilla A, Verdecchia A et al (2009) Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015. Cancer 115:1954-1966
4. International Agency for Research on Cancer (IARC) 2012 EUCAN http://eco.iarc.fr/EUCAN. Accessed 8 May 2014
5. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
6. Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC Med 9:48
7. Agnoli C, Berrino F, Abagnato CA et al (2010) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 20:41-48
8. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35:2402-2411
9. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington
10. Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627-635
11. Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti IA (2012) Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS ONE 7:e51446
12. Villarini A, Pasanisi P, Traina A et al (2012) Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori 98:1-18
13. Haftenberger M, Lahmann PH, Panico S et al (2002) Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European prospective investigation into cancer and nutrition (EPIC). Public Health Nutr 5:1147-1162
14. Istituto Superiore Sanità (ISS) (2013). Progetto Cuore-http://www.cuore.iss.it. Accessed 8 May 2014
15. Verdecchia A, Sant M, Gatta G, Micheli A, Berrino F, ITACARE Working Group (1997) Survival in adult Italian cancer patients, 1978-1989. Tumori 83:39-425
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
17. Contiero P, Berrino F, Tagliabue G et al (2013) Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study. Breast Cancer Res Treat 138:951-959
18. Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30:164-171
19. Minicozzi P, Berrino F, Sebastiani F et al (2013) High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. Eur J Cancer 49:3881-3888
20. Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963-968
21. Kumar NB, Cantor A, Allen K, Cox CE (2000) Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer 88:2751-2757
22. Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50:2341-2346
23. Strohmaier S, Edlinger M, Manjer J et al (2013) Total serum cholesterol and cancer incidence in the metabolic syndrome and cancer project (Me-Can). PLoS ONE 8:e54242
24. Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F (2010) Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort. Eur J Cancer Prev 19:120-125
25. Hiatt RA, Friedman GD, Bawol RD, Ury HK (1982) Breast cancer and serum cholesterol. J Natl Cancer Inst 68:885-889
26. Manjer J, Kaaks R, Riboli E, Berglund G (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo preventive project. Eur J Cancer Prev 10:33-42
27. Melvin JC, Seth D, Holmberg L et al (2012) Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 21:1381-1384
28. Schatzkin A, Hoover RN, Taylor PR et al (1988) Site-specific analysis of total serum cholesterol and incident cancer in the national health and nutrition examination survey I epidemiologic follow-up study. Cancer Res 48:452-458
29. Tornberg SA, Holm LE, Carstensen JM (1988) Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27:31-37
30. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152-1160
31. Hoyer AP, Engholm G (1992) Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control 3:403-408
32. Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR (2008) HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 18:671-677
33. Gaard M, Tretli S, Urdal P (1994) Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control 5:501-509
34. Bahl M, Ennis M, Tannock IF et al (2005) Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat 94:135-144
35. Largent JA, Bernstein L, Horn-Ross PL et al (2010) Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort. Cancer Causes Control 21:1615-1624
36. Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE (2000) Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 18:249-254
37. Nechuta S, Lu W, Zheng Y et al (2013) Comorbidities and breast cancer survival: a report from the Shanghai breast cancer survival study. Breast Cancer Res Treat 139:227-235
38. Braithwaite D, Tammemagi CM, Moore DH et al (2009) Hypertension is an independent predictor of survival disparity between African - American and white breast cancer patients. Int J Cancer 124:1213-1219
39. Bjorge T, Lukanova A, Jonsson H et al (2010) Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 19:1737-1745
40. Capasso I, Esposito E, Pentimalli F et al (2010) Metabolic syndrome affects breast cancer risk in postmenopausal women: national cancer institute of Naples experience. Cancer Biol Ther 10:1240-1243
41. Kabat GC, Kim M, Chlebowski RT et al (2009) A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 18:2046-2053
42. Maiti B, Kundranda MN, Spiro TP, Daw HA (2010) The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121:479-483
43. Healy LA, Ryan AM, Carroll P et al (2010) Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 22:281-288
44. Duggan C, Irwin ML, Xiao L et al (2011) Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 29:32-39
45. Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499-502
46. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51
47. Micheli A, Meneghini E, Secreto G et al (2007) Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 25:2685-2690
48. Allin KH, Nordestgaard BG, Flyger H, Bojesen SE (2011) Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res 13:R55
49. Pierce BL, Ballard-Barbash R, Bernstein L et al (2009) Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 27:3437-3444
50. Villasenor A, Flatt SW, Marinac C, Natarajan L, Pierce JP, Patterson RE (2013) Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study. Cancer Epidemiol Biomarkers Prev 22(1):32-41
51. Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the women's intervention nutrition study. J Natl Cancer Inst 98:1767-1776
52. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440-1446